ID

14860

Descrizione

Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors; ODM derived from: https://clinicaltrials.gov/show/NCT02352779

collegamento

https://clinicaltrials.gov/show/NCT02352779

Keywords

versioni (2)
  1. 02/05/16 02/05/16 -
  2. 20/09/21 20/09/21 -
Caricato su

2 maggio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Carcinoma NCT02352779

Inglese

Eligibility Breast Carcinoma NCT02352779

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
have a confirmed diagnosis of breast cancer; participants can have had more than one primary cancer diagnosis in the past
Descrizione

Breast Carcinoma | Primary malignant neoplasm Past

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C1306459
UMLS CUI [2,2]
C1444637
have undergone some type or combination of standard adjuvant treatment (surgery, chemotherapy, radiation therapy) for breast cancer
Descrizione

Adjuvant therapy Breast Carcinoma | Operative Surgical Procedures | Chemotherapy Regimen | Therapeutic radiology procedure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0677850
UMLS CUI [1,2]
C0678222
UMLS CUI [2]
C0543467
UMLS CUI [3]
C0392920
UMLS CUI [4]
C1522449
have completed all forms of standard adjuvant treatment (surgery, chemotherapy, radiation therapy) for breast cancer between 4 and 36 months prior to enrollment in the study; participants can be currently taking hormones (such as tamoxifen) or monoclonal antibodies (such as herceptin)
Descrizione

Adjuvant therapy Breast Carcinoma completed | Operative Surgical Procedures | Chemotherapy Regimen | Therapeutic radiology procedure | Hormone preparation | Tamoxifen | Monoclonal antibodies, antineoplastic | Herceptin

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0677850
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C1556116
UMLS CUI [2]
C0543467
UMLS CUI [3]
C0392920
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0019928
UMLS CUI [6]
C0039286
UMLS CUI [7]
C3542957
UMLS CUI [8]
C0338204
must have cancer-related fatigue, as indicated by a response of 4 or greater when asked to rate their level of fatigue at its worst in the past week on an 11-point scale anchored by "0" = no fatigue and "10" = as bad as you can imagine
Descrizione

Fatigue Malignant Neoplasms | Level of fatigue

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0015672
UMLS CUI [1,2]
C0006826
UMLS CUI [2]
C2586108
be able to read english
Descrizione

Able to read English Language

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0586740
UMLS CUI [1,2]
C0376245
able to swallow medication
Descrizione

Able to swallow oral medication

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
give written informed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
have used marine omega-3 supplements at any time within previous 3 months (this includes prescription omega-3 drugs such as lovaza®)
Descrizione

Omega-3 Fatty Acids | Pharmaceutical Preparations Lovaza

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0015689
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0912903
be taking anticoagulant medication (does not include aspirin)
Descrizione

Anticoagulants | Aspirin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0003280
UMLS CUI [2]
C0004057
have sensitivity or allergy to fish and/or shellfish
Descrizione

Hypersensitivity Fishes | Hypersensitivity Shellfish

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0016163
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1304606
have sensitivity or allergy to soy and/or soybeans
Descrizione

Hypersensitivity Soy | Hypersensitivity Soybeans

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2756587
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0037733
have confirmed diagnosis of chronic fatigue syndrome or other diagnosis known to cause severe fatigue
Descrizione

Chronic Fatigue Syndrome | Diagnosis Causing Fatigue Severe

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0015674
UMLS CUI [2,1]
C0011900
UMLS CUI [2,2]
C0678227
UMLS CUI [2,3]
C0015672
UMLS CUI [2,4]
C0205082
Ritorna all'inizio della pagina

Similar models

Eligibility Breast Carcinoma NCT02352779

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma | Primary malignant neoplasm Past
Item
have a confirmed diagnosis of breast cancer; participants can have had more than one primary cancer diagnosis in the past
boolean
C0678222 (UMLS CUI [1])
C1306459 (UMLS CUI [2,1])
C1444637 (UMLS CUI [2,2])
Adjuvant therapy Breast Carcinoma | Operative Surgical Procedures | Chemotherapy Regimen | Therapeutic radiology procedure
Item
have undergone some type or combination of standard adjuvant treatment (surgery, chemotherapy, radiation therapy) for breast cancer
boolean
C0677850 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Adjuvant therapy Breast Carcinoma completed | Operative Surgical Procedures | Chemotherapy Regimen | Therapeutic radiology procedure | Hormone preparation | Tamoxifen | Monoclonal antibodies, antineoplastic | Herceptin
Item
have completed all forms of standard adjuvant treatment (surgery, chemotherapy, radiation therapy) for breast cancer between 4 and 36 months prior to enrollment in the study; participants can be currently taking hormones (such as tamoxifen) or monoclonal antibodies (such as herceptin)
boolean
C0677850 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1556116 (UMLS CUI [1,3])
C0543467 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0019928 (UMLS CUI [5])
C0039286 (UMLS CUI [6])
C3542957 (UMLS CUI [7])
C0338204 (UMLS CUI [8])
Fatigue Malignant Neoplasms | Level of fatigue
Item
must have cancer-related fatigue, as indicated by a response of 4 or greater when asked to rate their level of fatigue at its worst in the past week on an 11-point scale anchored by "0" = no fatigue and "10" = as bad as you can imagine
boolean
C0015672 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C2586108 (UMLS CUI [2])
Able to read English Language
Item
be able to read english
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Able to swallow oral medication
Item
able to swallow medication
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Informed Consent
Item
give written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Omega-3 Fatty Acids | Pharmaceutical Preparations Lovaza
Item
have used marine omega-3 supplements at any time within previous 3 months (this includes prescription omega-3 drugs such as lovaza®)
boolean
C0015689 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0912903 (UMLS CUI [2,2])
Anticoagulants | Aspirin
Item
be taking anticoagulant medication (does not include aspirin)
boolean
C0003280 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
Hypersensitivity Fishes | Hypersensitivity Shellfish
Item
have sensitivity or allergy to fish and/or shellfish
boolean
C0020517 (UMLS CUI [1,1])
C0016163 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1304606 (UMLS CUI [2,2])
Hypersensitivity Soy | Hypersensitivity Soybeans
Item
have sensitivity or allergy to soy and/or soybeans
boolean
C0020517 (UMLS CUI [1,1])
C2756587 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0037733 (UMLS CUI [2,2])
Chronic Fatigue Syndrome | Diagnosis Causing Fatigue Severe
Item
have confirmed diagnosis of chronic fatigue syndrome or other diagnosis known to cause severe fatigue
boolean
C0015674 (UMLS CUI [1])
C0011900 (UMLS CUI [2,1])
C0678227 (UMLS CUI [2,2])
C0015672 (UMLS CUI [2,3])
C0205082 (UMLS CUI [2,4])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial